• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • Write for us
  • Contact us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • The Scan
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • AccountLog-in/out
    • Subscribe
    • Sign-in
    • My account
2 Minute Medicine
  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • The Scan
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • AccountLog-in/out
    • Subscribe
    • Sign-in
    • My account
SUBSCRIBE
2 Minute Medicine
Subscribe
Home StudyGraphics

#VisualAbstract: Aspirin associated with significantly higher rate of symptomatic venous thromboembolism compared to enoxaparin in patients undergoing hip or knee arthroplasty

byMinjee Kim
September 8, 2022
in StudyGraphics
Reading Time: 3 mins read
0
Share on FacebookShare on Twitter

 

1. In this random1. In this randomized controlled trial that included 9711 patients undergoing hip or knee arthroplasty, treatment with aspirin vs enoxaparin resulted in symptomatic VTE in 3.45% vs 1.82% of patients, respectively.

2. Death within 90 days occurred in 0.07% of patients in the aspirin group and 0.05% in the enoxaparin group.

Evidence Rating Level: 1 (Excellent)

Study Rundown: Venous thromboembolism (VTE) occurs in approximately 2% of patients following hip and knee arthroplasty procedures. The use of aspirin for thromboprophylaxis has increased between 2010 and 2021 due to its low cost, perceived safety and ease of administration. However, limited evidence exists regarding the safety and efficacy of aspirin as a sole prophylactic agent, hence the objective of this study was to determine whether aspirin was noninferior to enoxaparin in preventing symptomatic VTE after total hip arthroplasty (THA) or total knee arthroplasty (TKA). A total of 9711 patients undergoing THA or TKA were enrolled in this trial between April 2019 and December 2020. Patients were randomized to receive either 100mg/d of aspirin (n=5675) or 40mg/d of enoxaparin (n=4036) for 35 days post-THA and for 14 days post-TKA. The primary outcome in this study was symptomatic VTE within 90 days, which included pulmonary embolism and deep venous thrombosis. Secondary outcomes included death and major bleeding within 90 days. Within 90 days of surgery, symptomatic VTE occurred in 256 patients, with 79 cases of PE, 18 cases of above-knee DVT and 174 cases of below-knee DVT. The rate of symptomatic VTE in the aspirin group was 3.45%, and in the enoxaparin group it was 1.82%. A limitation to this study was the loss to follow-up at a rate of 5.2%, which could have led to some outcomes being missed. A strength of this study was its large sample size.

Click to read the study in JAMA

Click to read an accompanying editorial in JAMA

RELATED REPORTS

#VisualAbstract: Thromboprophylaxis with aspirin is non-inferior to low-molecular-weight heparin in preventing death for patients with orthopedic trauma

Variations in the use of cemented implants for hip fracture repair in Nova Scotia

Extended rivaroxaban treatment reduces recurrence rate for patients with deep vein thrombosis

Relevant Reading: Aspirin versus enoxaparin for the initial prevention of venous thromboembolism following elective arthroplasty of the hip or knee: a systematic review and meta-analysis

In-Depth [randomized controlled trial]: In this study, a total of 9711 patients were included (median age, 68 years; 56.8% female). Within 90 days of THA or TKA, symptomatic VTE occurred at a rate of 3.45% (187 of 5416 patients) in the aspirin group, and 1.82% (69 of 3787 patients) in the enoxaparin group (estimated difference, 1.97%; 95% CI, 0.54%-3.41%). This trial demonstrated significant superiority for enoxaparin (P=.007), and failed to meet the criterion for noninferiority for aspirin. Death within 90 days occurred in 4 of 5675 patients (0.07%) in the aspirin group and 2 of 4036 patients (0.05%) in the enoxaparin group (estimated difference, 0.05%; 95% CI, -0.05% to 0.15%). Major bleeding events occurred in 17 of 5401 patients (0.31%) in the aspirin group, and 15 of 3779 patients (0.40%) in the enoxaparin group (estimated difference, -0.05%; 95% CI, -0.25% to 0.04%). The median time to diagnosis of symptomatic VTE was 7.5 days (IQR, 5-19 days) in the aspirin group and 12 days (IQR, 7-25 days) in the enoxaparin group.

©2022 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.

Tags: anticoagulationaspirindeep venous thromboembolismdvtenoxaparinhip arthroplastyknee arthroplastyLovenoxPEpostsurgical anticoagulationpulmonary embolismrctTHAthromboembolismtkatotal hip arthroplaastytotal knee arthroplastyvenous thromboembolismVTE
Previous Post

Factors associated with greater severity of COVID-19 disease among solid transplant recipients

Next Post

Wellness Check: Nutrition

RelatedReports

#VisualAbstract: Thromboprophylaxis with aspirin is non-inferior to low-molecular-weight heparin in preventing death for patients with orthopedic trauma
StudyGraphics

#VisualAbstract: Thromboprophylaxis with aspirin is non-inferior to low-molecular-weight heparin in preventing death for patients with orthopedic trauma

January 24, 2023
Bisphosphonate use and risk of atypical femur fractures
Orthopedic Surgery

Variations in the use of cemented implants for hip fracture repair in Nova Scotia

December 19, 2022
Thrombophilia-associated stillbirth risk appears limited to factor V Leiden
Cardiology

Extended rivaroxaban treatment reduces recurrence rate for patients with deep vein thrombosis

December 7, 2022
Women electing abortion more likely to be victims of domestic violence
Chronic Disease

Low-dose low-molecular weight heparin comparable to intermediate-dose for risk of venous thromboembolism in peripartum women

November 29, 2022
Next Post
Improved glycemic control in type 1 diabetics on very low-carbohydrate diets

Wellness Check: Nutrition

The ABCD2 score: Risk of stroke after Transient Ischemic Attack (TIA) [Classics Series]

The ISAT trial: endovascular coiling superior to neurosurgical clipping in selected patients with aneurysmal subarachnoid hemorrhage [Classics Series]

Hematopoietic stem-cell transplantation may increase risk of fractures

Vamorolone associated with loss of bone morbidities compared with prednisone in boys with Duchenne muscular dystrophy

License Our Award-Winning Physician-Written Medical News and Visual Abstracts

2 Minute Medicine is the leading authoritative medical news licensing service, and the only with reports written by practicing doctors.

LICENSE CONTENT

2MM+ Premium Access

No ads & unlimited access to all current reports, over 9000 searchable archived reports, visual abstracts, Weekly Rewinds, and the online edition of The Classics Series™ textbook.

Subscription Options
2 Minute Medicine

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Catheter ablation reduces rates of persistent atrial fibrillation and atrial tachyarrhythmia
  • Deep intronic FGF14 repeat expansion associated with late-onset cerebella ataxia
  • Plant-based diets may be associated with lower risk of aggressive prostate cancer
License Content
Terms of Use | Disclaimer
Cookie Policy
Privacy Statement (EU)
Disclaimer

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.

  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • The Scan
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.

Want more physician-written
medical news?

Join over 10 million yearly readers and numerous companies. For healthcare professionals
and the public.

Subscribe for free today!

Subscription options